Elevated ANGPTL4 levels have been reported in the plasma of both HFpEF and HFrEF patients [57], suggesting that more phenotypically fine-grained plasma studies are needed to dissect the association of ANGPTL4 with the HF phenotypes and relevant comorbidities like obesity and atherosclerosis. This evidence concerns the gene ANGPTL4 and hydrops fetalis.